JP6318096B2 - 希土類酸化物粒子及び特に画像化におけるその使用 - Google Patents

希土類酸化物粒子及び特に画像化におけるその使用 Download PDF

Info

Publication number
JP6318096B2
JP6318096B2 JP2014560435A JP2014560435A JP6318096B2 JP 6318096 B2 JP6318096 B2 JP 6318096B2 JP 2014560435 A JP2014560435 A JP 2014560435A JP 2014560435 A JP2014560435 A JP 2014560435A JP 6318096 B2 JP6318096 B2 JP 6318096B2
Authority
JP
Japan
Prior art keywords
particles
formula
particle
imaging
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014560435A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015514689A (ja
JP2015514689A5 (enExample
Inventor
スチョエッフェル マルクス
スチョエッフェル マルクス
アレクアンドロウ アンティゴニ
アレクアンドロウ アンティゴニ
ボウジグエス セドリク
ボウジグエス セドリク
ガコイン ティエッリ
ガコイン ティエッリ
ボイロト ジャン‐ピエッレ
ボイロト ジャン‐ピエッレ
Original Assignee
エコール・ポリテクニク
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by エコール・ポリテクニク filed Critical エコール・ポリテクニク
Publication of JP2015514689A publication Critical patent/JP2015514689A/ja
Publication of JP2015514689A5 publication Critical patent/JP2015514689A5/ja
Application granted granted Critical
Publication of JP6318096B2 publication Critical patent/JP6318096B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent materials, e.g. electroluminescent or chemiluminescent
    • C09K11/08—Luminescent materials, e.g. electroluminescent or chemiluminescent containing inorganic luminescent materials
    • C09K11/77—Luminescent materials, e.g. electroluminescent or chemiluminescent containing inorganic luminescent materials containing rare earth metals
    • C09K11/7783—Luminescent materials, e.g. electroluminescent or chemiluminescent containing inorganic luminescent materials containing rare earth metals containing two or more rare earth metals one of which being europium
    • C09K11/7794—Vanadates; Chromates; Molybdates; Tungstates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
JP2014560435A 2012-03-09 2013-03-08 希土類酸化物粒子及び特に画像化におけるその使用 Active JP6318096B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1252167 2012-03-09
FR1252167A FR2987831A1 (fr) 2012-03-09 2012-03-09 Particules d'oxyde a base de terres rares et utilisation notamment en imagerie
PCT/FR2013/050500 WO2013132197A1 (fr) 2012-03-09 2013-03-08 Particules d'oxyde à base de terres rares et utilisation notamment en imagerie

Publications (3)

Publication Number Publication Date
JP2015514689A JP2015514689A (ja) 2015-05-21
JP2015514689A5 JP2015514689A5 (enExample) 2016-04-21
JP6318096B2 true JP6318096B2 (ja) 2018-04-25

Family

ID=48083471

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014560435A Active JP6318096B2 (ja) 2012-03-09 2013-03-08 希土類酸化物粒子及び特に画像化におけるその使用

Country Status (6)

Country Link
US (2) US20150010476A1 (enExample)
EP (1) EP2823016A1 (enExample)
JP (1) JP6318096B2 (enExample)
CN (1) CN104302731B (enExample)
FR (1) FR2987831A1 (enExample)
WO (1) WO2013132197A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2531336B (en) * 2014-10-17 2019-04-10 Thermo Fisher Scient Bremen Gmbh Method and apparatus for the analysis of molecules using mass spectrometry and optical spectroscopy
FR3069927B1 (fr) * 2017-08-04 2021-06-04 Ecole Polytech Procede de detection ultra-sensible a l'aide de particules photoluminescentes
US11357085B2 (en) * 2017-09-25 2022-06-07 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Adaptive solid-state luminescent phosphors
US11279656B2 (en) 2017-10-27 2022-03-22 Applied Materials, Inc. Nanopowders, nanoceramic materials and methods of making and use thereof
CN114381255B (zh) * 2021-10-25 2022-10-11 中国科学院福建物质结构研究所 一种放射性医用同位素标记的稀土掺杂纳米材料和pet显像诊疗剂及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE346898T1 (de) * 2003-04-30 2006-12-15 Nanosolutions Gmbh Kern-mantel nanoteilchen für (f) ret- testverfahren
ES2283674T3 (es) * 2003-04-30 2007-11-01 Centrum Fur Angewandte Nanotechnologie (Can) Gmbh Nanoparticulas de cucleos/recubrimientos luminiscentes.
CN101368098B (zh) * 2008-07-29 2011-07-13 浙江理工大学 YVO4:Eu3+/YPO4核壳结构纳米荧光粉及其制备方法
DE102009012698A1 (de) * 2009-03-11 2010-09-16 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Partikel mit einer lumineszierenden anorganischen Schale, Verfahren zur Beschichtung von Partikeln sowie deren Verwendung

Also Published As

Publication number Publication date
EP2823016A1 (fr) 2015-01-14
US20180161461A1 (en) 2018-06-14
FR2987831A1 (fr) 2013-09-13
WO2013132197A1 (fr) 2013-09-12
JP2015514689A (ja) 2015-05-21
CN104302731B (zh) 2016-09-14
US20150010476A1 (en) 2015-01-08
CN104302731A (zh) 2015-01-21

Similar Documents

Publication Publication Date Title
Zhang et al. Biomedical applications of lanthanide nanomaterials, for imaging, sensing and therapy
Cha et al. Functional mesoporous silica nanoparticles for bio‐imaging applications
Huang et al. Multimodality and nanoparticles in medical imaging
Prodi et al. Imaging agents based on lanthanide doped nanoparticles
Xu et al. Paramagnetic nanoparticle T 1 and T 2 MRI contrast agents
Zhou et al. Gadolinium complex and phosphorescent probe-modified NaDyF4 nanorods for T1-and T2-weighted MRI/CT/phosphorescence multimodality imaging
Ge et al. Lanthanide (Gd3+ and Yb3+) functionalized gold nanoparticles for in vivo imaging and therapy
Hahn et al. Nanoparticles as contrast agents for in-vivo bioimaging: current status and future perspectives
Teston et al. Design, properties, and in vivo behavior of superparamagnetic persistent luminescence nanohybrids
Cormode et al. Inorganic nanocrystals as contrast agents in MRI: synthesis, coating and introduction of multifunctionality
JP2011500652A (ja) 放射線増感剤としてのランタニド系ナノ粒子の使用
Jinlei et al. Simultaneous realization of persistent luminescence and CT dual-mode imaging by x-ray recharged Bi2Ga4O9: Cr nanoprobes in depth-independent tumors
US20180161461A1 (en) Rare Earth Oxide Particles and Use Thereof in Particular In Imaging
Cheng et al. Near infrared receptor-targeted nanoprobes for early diagnosis of cancers
Kitture et al. Hybrid nanostructures for in vivo imaging
Wu et al. Emerging nanoagents for medical X-ray imaging
Song et al. Tumor-targetable magnetoluminescent silica nanoparticles for bimodal time-gated luminescence/magnetic resonance imaging of cancer cells in vitro and in vivo
Song et al. A multifunctional nanoprobe based on europium (iii) complex–Fe 3 O 4 nanoparticles for bimodal time-gated luminescence/magnetic resonance imaging of cancer cells in vitro and in vivo
JP2015508747A (ja) ｉｎｖｉｖｏ光学イメージング、ｉｎｖｉｖｏ多モード光学−ＭＲＩイメージング、および治療的診断のためのｉｎｓｉｔｕで励起可能な持続的発光ナノ粒子
Chen Nanoplatform-based molecular imaging
KR100825939B1 (ko) 근적외선 형광체가 결합된 양친성 고분자의 나노 입자를포함하는 암 진단용 조영제
Tessitore et al. Lanthanide-doped nanoparticles in biological imaging and bioassays
Hollis et al. Hybrid nanocrystal as a versatile platform for cancer theranostics
Atabaev Multimodal inorganic nanoparticles for biomedical applications
JP7156665B2 (ja) 医薬、並びにその製造方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160303

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160303

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20161122

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20170220

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170522

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170711

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20170929

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180110

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20180111

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180306

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180402

R150 Certificate of patent or registration of utility model

Ref document number: 6318096

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150